@FierceBiotech: PacBio wants to offer sequencing machine users new cloud computing capabilities. Company is working with Cycle Computing. Story | Follow @FierceBiotech
@RyanMFierce: Cancer drug shortages keep getting worse, bad trend for developers and patients. Report | Follow @RyanMFierce
@MaureenFierce: Reading: Downsizing trend leaves pharma without the kinds of employees it needs. Story via @Pharmalot | Follow @MaureenFierce
> Valeant has bumped its bid for Afexa after a hostile suitor, Paladin Labs, offered to sweeten its own offer. Valeant says it will pay $85.4 million for Afexa in an effort aimed at adding Cold-FX to its list of marketed drugs. Story
> With up to $26 million in support from a Russian venture fund, Cleveland BioLabs is setting up a new subsidiary to develop to develop a portfolio of preclinical cancer drugs. Report
> Shares of Mela Sciences soared this morning after the company reported that regulators had alerted the biotech that its diagnostic tool for melanoma was on track to an approval. Story
> The JDFR will collaborate with iCo on a program to to investigate iCo-007 in diabetic macular edema. Release
> Amarin has submitted an NDA for AMR101. Release
Pharma News
@FiercePharma: While the EU takes more time to weigh its Cephalon deal, Teva agrees to buy out Japanese JV partner for $150M. Story | Follow @FiercePharma
> Cancer costs growing 'unsustainable,' expert panel says. Report
> Afinitor data could be 'game-changer' in breast cancer. Article
> Swiss paper totes up Novartis layoff count: 2,500. Story
Medical Device News
@FierceMedDev: Neat! Diagnostic Development Unit Is A Star Trek-Style Sick Bay Bed via PSFK. Report | Follow @FierceMedDev
> Delcath taps Miao as CFO. Story
> Occlutech CEO scores win against St Jude-AGA Medical. Item
> Mela receives approvable letter for cancer device. Report
> Bausch + Lomb makes exec moves. News
> PENTAX launches first HD video bronchoscope. Story
Biotech IT News
> NextDocs expands to West Coast. Report
> PacBio reaches for cloud tech amid biz slump. Report
> Brain Resource scores $10M, opens SF office. News
> NIH backs tech linking trial data, patient records. Story
> Computational analysis points to potential HIV targets. Article
And Finally... Investigators have zeroed in on a prime genetic suspect to explain why 40% of asthma patients don't respond to common therapies. Story